Lapses in care among patients assigned to ranibizumab for proliferative diabetic retinopathy: a post hoc analysis of a randomized clinical trial
… We describe the frequency and pattern of lapses in follow-up among participants assigned to ranibizumab in Protocol S, identify baseline factors associated with lapses in follow-up, and …..... Read More